# Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

Study · id `cardio:ct-nct05696444` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05696444](<https://clinicaltrials.gov/study/NCT05696444>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05696444

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 144 participants.

## Technical summary

Registry record NCT05696444. Allocation not applicable; no masking; primary purpose treatment. Start 2022-12-14 (actual); primary completion 2024-10-10 (actual). Results posted on 2025-11-25.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 144 participants (enrolled count; ClinicalTrials.gov record NCT05696444, source copy `cardio:ctgov-nct05696444-2026-11-03`, retrieved 2026-11-18)
- Started: 2022-12-14 (actual) (ClinicalTrials.gov record NCT05696444, source copy `cardio:ctgov-nct05696444-2026-11-03`, retrieved 2026-11-18)
- Primary completion: 2024-10-10 (actual) (ClinicalTrials.gov record NCT05696444, source copy `cardio:ctgov-nct05696444-2026-11-03`, retrieved 2026-11-18)
- Completion: 2030-01-31 (anticipated) (ClinicalTrials.gov record NCT05696444, source copy `cardio:ctgov-nct05696444-2026-11-03`, retrieved 2026-11-18)
- Results first posted: 2025-11-25 (ClinicalTrials.gov record NCT05696444, source copy `cardio:ctgov-nct05696444-2026-11-03`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT05696444, source copy `cardio:ctgov-nct05696444-2026-11-03`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05696444-2026-11-03`, retrieved 2026-11-18)

## The registry's words

- Brief title: Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
- Condition: Bladder Cancer
- Condition: Prostate Cancer
- Condition: Kidney Cancer
- Condition: Pelvic Tumor
- Condition: Interstitial Cystitis
- Condition: Congenital Abnormalities
- Condition: End Stage Renal Disease
- Condition: Renal Tumor
- Condition: Kidney Injury
- Intervention (Device): RAS Prostatectomy
- Intervention (Device): RAS Cystectomy
- Intervention (Device): RAS Nephrectomy
- Lead sponsor: Medtronic - MITG
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Medtronic - MITG (`cardio:org-medtronic-mitg`)

## Provenance

Content hash: 53b61428095022b92bd0fac2fe1b302bc79818301c36fa18e91dbb9f33744193
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
